Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 20 Rectal Neoplasms 12 Colonic Neoplasms 11 Head and Neck Neoplasms 6 Neoplasm Metastasis 5 Carcinoma, Hepatocellular 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Neoplasms 3 Keratosis, Actinic 3 Esophageal Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Skin Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Nasopharyngeal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Biliary Tract Neoplasms 2 Adenocarcinoma Of Esophagus 2 Tongue Neoplasms 1 Recurrence 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Motor Activity 1 Melanoma 1 Malignant Tumor of Pancreas Metastatic to Liver 1 Lymphoma, Non-Hodgkin 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Leukoplakia, Oral × Fluorouracil × Clear all

NCT05505539 2022-09-22

OL_5FU

University of California, San Francisco

Phase 1 Withdrawn

Leukoplakia, Oral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡